Antibody that protects against many COVID-19 variants
While the world is suffering under the fangs of COVID-19, researchers are trying to find different ways to protect against it.
A team of researchers from Washington University identified an antibody that can protect against many variants of COVID-19.
They identified that this antibody is highly protective at low doses against numerous Covid-19 variants.
Michael S. Diamond, one of the researchers, said that current antibodies can protect against only a few variants of COVID-19. However, the antibody they identified is effective enough to protect against many different variants of COVID-19. Its mechanism of working is also different.
He added that as the virus may continue to evolve in future, effective and paired antibodies are essential to prevent its resistance. In other words, there is a need of neutralising antibodies that work effectively and can protect against numerous variants.
To find these antibodies, the researchers started the process by immunising mice using a key part of the spike protein of the coronavirus. The spike protein plays a vital role in the receptor recognition and binding process.
The researchers extracted antibody-producing cells from which they obtained 43 antibodies to recognize the receptor-binding domain.
They screened all these antibodies and evaluated their efficiency in preventing the original variant of SARS-CoV-2 that emerged in 2019.
Then they selected the two most effective antibodies that could protect mice from disease and against a panel of viral variants, including alpha, beta, gamma and delta. The panel includes many other unnamed variants also.
Between the two, one antibody, SARS2-38, neutralized all the variants of COVID-19. Thus, the researchers found an antibody that can effectively protect against multiple variants of COVID-19.
The study was published in the journal, Immunity. It paves way for developing new and effective antibody-based therapies that do not lose their potency as the coronavirus mutates over time.
Image by Shafin Al Asad Protic from Pixabay (Free for commercial use)
You may also like
Image Reference: https://pixabay.com/vectors/corona-covid-19-vaccine-virus-5974596/
Recent Posts
- India’s BrahMos-NG, a leap in defence strengthThe new Lucknow facility will exclusively produce BrahMos-NG, marking Uttar Pradesh’s growing role in defence manufacturing.
- No talks on Kashmir, terror will be met with Force: IndiaIndia has made its position clear: there will be no talks on Kashmir.
- Delhi-Amritsar Bullet Train on track for 2025 completionThe Delhi-Amritsar High-Speed Rail (DAMHSR) project is a proposed 465 km bullet train corridor connecting Delhi, Chandigarh, and Amritsar. Currently in the planning phase, the project aims to be completed by December 31, 2025.
- India’s BrahMos-NG, a leap in defence strength
What’s new at WeRIndia.com
News from 700+ sources
-
Vizag Dazzles As Golden Shower Trees Blossom In City
-
ED May Act Against Lavidiya
-
Congress worker killed by Maoists in Chhattisgarhs Bijapur
-
Cyberabad police recover 310 mobile phones worth 95 lakh in a month
-
Staff organisation objects to unlawful inspection at KTU
-
Even a16z VCs say no one really knows what an AI agent is
-
WeRIndia – A News Aggregator
Visit werindia.com for all types of National | Business | World | Politics | Entertainment | Health related news and much more..
Leave a Reply